Eli Lilly and Company logo

Eli Lilly and Company LLY

$ 1 074.68 -0.47%

Quarterly report 2025-Q2
added 08-07-2025

report update icon

Country

usaUSA

IPO year

-

Industry

Biotechnology

Stock Exchange

NYSESPB

Shares

901 M

Market Cap[1]

$ 968 B

EBITDA (LTM)

$ 2.37 B

P/E (LTM)

78.22

P/S (LTM)

18.97

EPS (LTM)

13.74

Eli Lilly and Company is one of the world's largest pharmaceutical companies, specializing in the development, manufacturing, and sale of innovative drugs for the treatment of various diseases.

The company was founded in 1876 in Indianapolis, Indiana and has since become a leader in the pharmaceutical industry. Eli Lilly and Company develops and manufactures a wide range of drugs, including those for diabetes, cancer, mental disorders, Alzheimer's disease, and other illnesses.

One of the company's most well-known developments is insulin, which was created in 1923. This drug became the first effective treatment for diabetes and has saved millions of lives worldwide.

Eli Lilly and Company actively invests in research and development of new drugs to help patients worldwide fight various diseases. The company also aims to improve the quality of life for patients by providing them with access to high-quality drugs. Is a global company with operations in more than 125 countries. The company cares about its employees and society as a whole, participating in various charitable projects and social responsibility programs.

Overall, is one of the most successful and innovative companies in the pharmaceutical industry. Its products help millions of people worldwide overcome difficulties associated with various diseases and improve their quality of life.

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
AgeX Therapeutics AgeX Therapeutics
AGE
- -10.17 % $ 12.2 K NYSE American usaUSA
AIkido Pharma AIkido Pharma
AIKI
- 1.93 % $ 17.4 M Nasdaq Capital Market usaUSA
MorphoSys AG MorphoSys AG
MOR
- 2.43 % $ 254 M Nasdaq Global Select Market germanyGermany
Aclaris Therapeutics Aclaris Therapeutics
ACRS
$ 3.01 3.79 % $ 233 M Nasdaq Global Select Market usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
$ 3.08 0.65 % $ 7.41 B Nasdaq Capital Market australiaAustralia
AlloVir AlloVir
ALVR
- 4.14 % $ 49.1 M Nasdaq Global Select Market usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
- -11.43 % $ 502 K NYSE American usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
- - $ 2.17 B Nasdaq Global Market usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
- -18.52 % $ 27.3 M Nasdaq Global Select Market britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
- - $ 40.3 B Nasdaq Global Select Market usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
- - $ 10.1 M Nasdaq Global Select Market,SPB usaUSA
Biophytis SA Biophytis SA
BPTS
- -13.47 % $ 169 M Nasdaq Capital Market franceFrance
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
- - $ 1.01 B Nasdaq Global Market usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
- -1.52 % $ 24.7 M Nasdaq Capital Market usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
- -52.27 % $ 4.45 M Nasdaq Global Select Market usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
$ 1.99 1.02 % $ 508 M Nasdaq Global Select Market britainBritain
AVROBIO AVROBIO
AVRO
- 1083.1 % $ 745 M Nasdaq Global Select Market usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
$ 213.24 1.87 % $ 5 B Nasdaq Global Select Market danmarkDanmark
BioDelivery Sciences International BioDelivery Sciences International
BDSI
- -4.8 % $ 255 M Nasdaq Global Select Market usaUSA
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$ 11.29 -3.01 % $ 730 M NYSE usaUSA
BioVie BioVie
BIVI
$ 1.16 2.65 % $ 1.71 M Nasdaq Capital Market usaUSA
Athersys Athersys
ATHX
- 3.77 % $ 22.4 M Nasdaq Capital Market usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
- - - MOEX russiaRussia
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
- -9.72 % $ 5.89 M Nasdaq Capital Market usaUSA
Berkeley Lights Berkeley Lights
BLI
- -7.31 % $ 87 M Nasdaq Global Select Market usaUSA
ARCA biopharma ARCA biopharma
ABIO
- 1052.0 % $ 415 M Nasdaq Capital Market usaUSA
Acasti Pharma Acasti Pharma
ACST
- 4.01 % $ 150 M Nasdaq Capital Market canadaCanada
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
- -15.15 % $ 60.3 M Nasdaq Global Select Market britainBritain
bluebird bio bluebird bio
BLUE
- - $ 546 M Nasdaq Global Select Market,SPB usaUSA
Albireo Pharma Albireo Pharma
ALBO
- -0.23 % $ 916 M Nasdaq Capital Market usaUSA
BioNTech SE BioNTech SE
BNTX
$ 95.2 -0.08 % $ 27.2 B Nasdaq Global Select Market germanyGermany
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
$ 0.2 8.46 % $ 435 M NYSE American israelIsrael
Calithera Biosciences Calithera Biosciences
CALA
- -10.95 % $ 876 K Nasdaq Global Select Market usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
$ 26.78 -0.81 % $ 1.3 B Nasdaq Global Select Market usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
- 0.49 % $ 251 B Nasdaq Global Select Market cayman-islandsCayman-islands
Anika Therapeutics Anika Therapeutics
ANIK
$ 9.61 0.63 % $ 141 M Nasdaq Global Select Market,SPB usaUSA
Catalyst Biosciences Catalyst Biosciences
CBIO
$ 11.86 2.24 % $ 781 M Nasdaq Capital Market usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
- -6.81 % $ 3.04 B Nasdaq Global Select Market,SPB usaUSA
Acer Therapeutics Acer Therapeutics
ACER
- 2.71 % $ 14 M Nasdaq Capital Market usaUSA
Certara Certara
CERT
$ 8.81 -0.56 % $ 1.41 B Nasdaq Global Select Market usaUSA
Axon Enterprise Axon Enterprise
AXON
$ 567.93 -0.73 % $ 43 B Nasdaq Global Select Market,SPB usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
- - $ 7.46 M Nasdaq Global Market israelIsrael
Aytu BioScience Aytu BioScience
AYTU
$ 2.6 1.96 % $ 16.3 M Nasdaq Capital Market usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
$ 91.93 -0.63 % $ 96.9 B Nasdaq Global Select Market britainBritain
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
- - $ 169 M Nasdaq Capital Market usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
- -24.86 % $ 820 K Nasdaq Global Select Market usaUSA
Brickell Biotech Brickell Biotech
BBI
- -5.38 % $ 6.06 M Nasdaq Capital Market usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
$ 27.16 2.76 % $ 1.75 M Nasdaq Global Select Market usaUSA
Burford Capital Limited Burford Capital Limited
BUR
$ 8.92 -1.0 % $ 1.46 B NYSE britainBritain
Cellectis S.A. Cellectis S.A.
CLLS
$ 4.84 1.26 % $ 116 M Nasdaq Global Market franceFrance

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.